Page 12 - CSHS 2022 Book of Abstracts - 2022-08-22 web version
P. 12

CSHS 2022 Conference


             Cannabis & High Value Plants Symposium



             Symposium Chair: Dr. Youbin Zheng

             Abstracts – Invited Speakers


             (CI.1) The Canadian cannabis industry: trends, challenges and the need for innovation
             Dr. Lasse Schulze
             The Chronos Group
             ________________
             Licensed cannabis producers are facing diverse growing conditions in Canada, a complex regulatory framework, and
             with an ever-increasing number of medical and recreational cannabis consumers, the cannabis industry needs to
             adapt to satisfy the demand. Growing the industry at this scale is a formidable challenge and inherently comes with
             scientific, technical and operational obstacles. Here we present industry trends, and discuss how best-practices from
             related industries and innovations from the cannabis space are driving the industry forward, to ensure a consistent
             supply of high quality cannabis for patients and recreational users alike.


             (CI.2) Understanding and managing the important diseases of cannabis
             Dr. Zamir Punja
             Department of Biological Sciences, Simon Fraser University, Burnaby, BC
             ________________
             Commercial production of drug-type Cannabis sativa L. (marijuana, cannabis) containing the psychoactive
             compound  Δ 9- tetrahydrocannabinol occurs in controlled environment growing spaces indoors, in greenhouses,
             and under field conditions in Canada. Since legalization in 2018, the production of cannabis has increased steadily,
             with a majority under greenhouse cultivation. This has been accompanied by an associated increase in the number
             of pathogens causing losses in plant growth, quality and yield. At present, more than 40 fungal, oomycete, bacterial,
             viral and viroid pathogens have been identified that pose challenges for cannabis growers. In addition, post-harvest
             microbial contamination of cannabis products is an on-going challenge. Producers have adopted creative
             approaches to reduce the impact of plant pathogens and produce a high quality product that meets Health Canada
             standards. Management approaches include the implementation of sanitary practices, quarantines, application of
             disinfectants, and biological and cultural approaches. In this presentation, the important pathogens that pose the
             most threat to cannabis production will be discussed. These include Fusarium and Pythium root rots, powdery
             mildew, Botrytis bud rot, Hop Latent Viroid, and yeast and mold contamination. Spread of these microbes occurs
             rapidly within a growing facility and the unrestricted movement of plant materials from one licensed producer to
             another has been a major means of spread. Routine testing for the presence of plant pathogens using molecular
             diagnostic methods that have been recently developed is an important component of a disease management
             strategy.











                                                             12
   7   8   9   10   11   12   13   14   15   16   17